Literature DB >> 20160163

Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers.

P'ng Loke1, David Favre, Peter W Hunt, Jacqueline M Leung, Bittoo Kanwar, Jeffrey N Martin, Steven G Deeks, Joseph M McCune.   

Abstract

HIV "controllers" are persons infected with human immunodeficiency virus, type I (HIV) who maintain long-term control of viremia without antiviral therapy and who usually do not develop the acquired immune deficiency syndrome (AIDS). In this study, we have correlated results from polychromatic flow cytometry and oligonucleotide expression arrays to characterize the mucosal immune responses of these subjects in relation to untreated HIV(+) persons with high viral loads and progressive disease ("noncontrollers"). Paired peripheral blood and rectosigmoid biopsies were analyzed from 9 controllers and 11 noncontrollers. Several cellular immune parameters were found to be concordant between the 2 compartments. Compared with noncontrollers, the mucosal tissues of controllers had similar levels of effector T cells and fewer regulatory T cells (Tregs). Using principal component analysis to correlate immunologic parameters with gene expression profiles, transcripts were identified that accurately distinguished between controllers and noncontrollers. Direct 2-way comparison also revealed genes that are significantly different in their expression between controllers and noncontrollers, all of which had reduced expression in controllers. In addition to providing an approach that integrates flow cytometry datasets with transcriptional profiling analysis, these results underscore the importance of the sustained inflammatory response that attends progressive HIV disease.

Entities:  

Mesh:

Year:  2010        PMID: 20160163      PMCID: PMC2858476          DOI: 10.1182/blood-2009-12-257451

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

Review 1.  Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome.

Authors:  B J Van den Eynde; S Morel
Journal:  Curr Opin Immunol       Date:  2001-04       Impact factor: 7.486

2.  The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum.

Authors:  Molly A Accola; Bing Huang; Azzah Al Masri; Mark A McNiven
Journal:  J Biol Chem       Date:  2002-03-26       Impact factor: 5.157

3.  DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection.

Authors:  C B Bigger; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator.

Authors:  D B Bloch; A Nakajima; T Gulick; J D Chiche; D Orth; S M de La Monte; K D Bloch
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

5.  Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.

Authors:  Moraima Guadalupe; Elizabeth Reay; Sumathi Sankaran; Thomas Prindiville; Jason Flamm; Andrew McNeil; Satya Dandekar
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Authors:  Steven G Deeks; Christina M R Kitchen; Lea Liu; Hua Guo; Ron Gascon; Amy B Narváez; Peter Hunt; Jeffrey N Martin; James O Kahn; Jay Levy; Michael S McGrath; Frederick M Hecht
Journal:  Blood       Date:  2004-04-29       Impact factor: 22.113

7.  Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion.

Authors:  Howard M Lederman; Paige L Williams; Julia W Wu; Thomas G Evans; Susan E Cohn; J Allen McCutchan; Susan L Koletar; Richard Hafner; Elizabeth Connick; Fred T Valentine; M Juliana McElrath; Norbert J Roberts; Judith S Currier
Journal:  J Infect Dis       Date:  2003-12-08       Impact factor: 5.226

8.  Optimization of methods to assess human mucosal T-cell responses to HIV infection.

Authors:  Barbara L Shacklett; Otto Yang; Mary Ann Hausner; Julie Elliott; Lance Hultin; Charles Price; Marie Fuerst; Jose Matud; Patricia Hultin; Catherine Cox; Javier Ibarrondo; Johnson T Wong; Douglas F Nixon; Peter A Anton; Beth D Jamieson
Journal:  J Immunol Methods       Date:  2003-08       Impact factor: 2.303

9.  Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study.

Authors:  Jason F Okulicz; Vincent C Marconi; Michael L Landrum; Scott Wegner; Amy Weintrob; Anuradha Ganesan; Braden Hale; Nancy Crum-Cianflone; Judith Delmar; Vincent Barthel; Gerald Quinnan; Brian K Agan; Matthew J Dolan
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

10.  CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.

Authors:  Jason M Brenchley; Timothy W Schacker; Laura E Ruff; David A Price; Jodie H Taylor; Gregory J Beilman; Phuong L Nguyen; Alexander Khoruts; Matthew Larson; Ashley T Haase; Daniel C Douek
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

View more
  23 in total

1.  Killing the messenger to maintain control of HIV.

Authors:  Joel N Blankson
Journal:  Nat Med       Date:  2011-08-04       Impact factor: 53.440

2.  T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.

Authors:  Annette R Rodriguez; Vida Hodara; Kruthi Murthy; LaShayla Morrow; Melissa Sanchez; Amy E Bienvenu; Krishna K Murthy
Journal:  Cell Immunol       Date:  2014-02-06       Impact factor: 4.868

3.  Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.

Authors:  David Favre; Jeff Mold; Peter W Hunt; Bittoo Kanwar; P'ng Loke; Lillian Seu; Jason D Barbour; Margaret M Lowe; Anura Jayawardene; Francesca Aweeka; Yong Huang; Daniel C Douek; Jason M Brenchley; Jeffrey N Martin; Frederick M Hecht; Steven G Deeks; Joseph M McCune
Journal:  Sci Transl Med       Date:  2010-05-19       Impact factor: 17.956

4.  HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells.

Authors:  David Favre; Cheryl A Stoddart; Brinda Emu; Rebecca Hoh; Jeffrey N Martin; Frederick M Hecht; Steven G Deeks; Joseph M McCune
Journal:  Blood       Date:  2011-01-03       Impact factor: 22.113

5.  Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory.

Authors:  Thorsten Demberg; Amelia C Ettinger; Stanley Aladi; Katherine McKinnon; Thea Kuddo; David Venzon; L Jean Patterson; Terry M Phillips; Marjorie Robert-Guroff
Journal:  Vaccine       Date:  2011-06-25       Impact factor: 3.641

6.  Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers.

Authors:  Asier Sáez-Cirión; Chiraz Hamimi; Anna Bergamaschi; Annie David; Pierre Versmisse; Adeline Mélard; Faroudy Boufassa; Françoise Barré-Sinoussi; Olivier Lambotte; Christine Rouzioux; Gianfranco Pancino
Journal:  Blood       Date:  2011-06-03       Impact factor: 22.113

Review 7.  Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.

Authors:  Jean-François Gélinas; Deborah R Gill; Stephen C Hyde
Journal:  Microbiol Mol Biol Rev       Date:  2018-01-10       Impact factor: 11.056

8.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16

9.  Preclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenase.

Authors:  Richard M Dunham; Shari N Gordon; Monica Vaccari; Michael Piatak; Yong Huang; Steven G Deeks; Jeffrey Lifson; Genoveffa Franchini; Joseph M McCune
Journal:  AIDS Res Hum Retroviruses       Date:  2012-10-09       Impact factor: 2.205

10.  Use of principal components analysis and protein microarray to explore the association of HIV-1-specific IgG responses with disease progression.

Authors:  Helen L Gerns Storey; Barbra A Richardson; Benson Singa; Jackie Naulikha; Vivian C Prindle; Vladimir E Diaz-Ochoa; Phil L Felgner; David Camerini; Helen Horton; Grace John-Stewart; Judd L Walson
Journal:  AIDS Res Hum Retroviruses       Date:  2013-12-09       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.